Brandywine Global Investment Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $23.9M | Sell |
|
|||||
|
2022
Q4 | $60.2M | Sell |
|
|||||
|
2022
Q3 | $41.7M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $5K | Sell |
|
|||||
|
2020
Q1 | $1.1M | Sell |
|
|||||
|
2019
Q4 | $34.9M | Sell |
|
|||||
|
2019
Q3 | $29.5M | Buy |
|
|||||
|
2019
Q2 | $2.65M | Sell |
|
|||||
|
2019
Q1 | $31M | Sell |
|
|||||
|
2018
Q4 | $29.1M | Sell |
|
|||||
|
2018
Q3 | $48.5M | Sell |
|
|||||
|
2018
Q2 | $48.4M | Sell |
|
|||||
|
2018
Q1 | $53.2M | Sell |
|
|||||
|
2017
Q4 | $60.7M | Buy |
|
|||||
|
2017
Q3 | $50.9M | Buy |
|
|||||
|
2017
Q2 | $47M | Buy |
|
|||||
|
2017
Q1 | $52.2M | Buy |
|
|||||
|
2016
Q4 | $40.3M | Sell |
|
|||||
|
2016
Q3 | $48M | Sell |
|
|||||
|
2016
Q2 | $46.3M | Buy |
|
|||||
|
2016
Q1 | $40.9M | Buy |
|
|||||
|
2015
Q4 | $49.2M | Buy |
|